MedPath

Effect of Myoma Removal on Blood Pressure and Erythropoetin Level

Not Applicable
Completed
Conditions
Myoma
Hypertension
Interventions
Procedure: myoma removal
Registration Number
NCT00898170
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

The effect of myoma removal was studied on 28 patients with hypertension and myoma by holter monitoring and erythropoetin level check.

Detailed Description

Background:

Myoma is the most common gynecoid tumor and produces many vasoactive substances, which may be a cause for secondary hypertension. Early reports suggested the association of myoma and hypertension. We studied the effect of myoma removal on hypertension and erythropoietin level to evaluate this hypothesis.

Patients \& Methods:

In this single centered prospective cohort study, in twenty eight patients who were candidates for myomectomy due to myoma, 24 hour holter monitoring of blood pressure and serum erythropoietin were checked before and 6 weeks after hysterectomy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
28
Inclusion Criteria
  • candidate for myoma removal by hysterectomy
  • operable
  • hysterectomy is indicated
Exclusion Criteria
  • patient refusal
  • inoperable patients
  • other secondary cases of hypertension

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
myoma, with or without hypertensionmyoma removalthose with myoma with or without hypertension in holter monitoring
Primary Outcome Measures
NameTimeMethod
24 hour holter monitoring of blood pressure6 weeks
Secondary Outcome Measures
NameTimeMethod
erythropoetin level6 weeks

Trial Locations

Locations (1)

Cardiology Ward Shiraz University of Medical Sciences

🇮🇷

Shiraz, Fars, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath